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Abstract
Enteroviruses like coxsackievirus B3 (CVB3) are common suspects in myocarditis/dilated cardiomyopathy patients. Autoimmunity has been proposed as an underlying mechanism, but direct evidence of its role is lacking. To delineate autoimmune response in CVB3 myocarditis, we used IAk dextramers for cardiac myosin heavy chain (Myhc)-α 334–352. We have demonstrated that myocarditis-susceptible A/J mice infected with CVB3 generate Myhc-α-reactive CD4 T cells and such a repertoire was
absent in naïve mice as measured by proliferative response to Myhc-α 334–352 and IAk dextramer staining. We also detected
Myhc-α 334–352 dextramer+ cells in the hearts of CVB3-infected mice. The autoreactive T cell repertoire derived from infected
mice contained a high frequency of interleukin-17-producing cells capable of inducing myocarditis in naïve recipients. The data
suggest that CVB3, a bona fide pathogen of cardiovascular system that primarily infects the heart can lead to the secondary generation of autoreactive T cells and contribute to cardiac pathology.
Abbreviations: 7-AAD, 7-aminoactinomycin D; ANT, adenine nucleotide translocator; BCKD, branched chain α-ketoacid dehydrogenase; CPE,
cytopathic effect; Con-A, concanavalin-A; cpm, counts per minute; CVB3, coxsackievirus B3; DCM, dilated cardiomyopathy; EAM, experimental autoimmune myocarditis; FC, flow cytometry; GM-CSF, granulocyte macrophage-colony stimulating factor; IFN, interferon; IL, interleukin; IRBP, interphotoreceptor retinoid-binding protein; LN, lymph nodes; MHC, major histocompatibility complex; MNC, mononuclear cells;
Myhc-α, cardiac myosin heavy chain-α; NASE, neuraminidase; PI, postinfection; PMA, phorbol 12-myristate 13-acetate; RNase, ribonuclease;
TCID50, 50% tissue culture infective dose; Th, T helper; TNF, tumor necrosis factor; TNI, cardiac troponin I.

1. Introduction
Heart failure is the leading cause of death in the United
States. It is estimated that 80 million American adults have
some form of cardiovascular disease, with a projected incidence of 40% by 2030 [1]. The potential causes of heart failure
include pericardial, coronary artery, or heart valve diseases, idiopathic cardiomyopathy, chronic ischemia, and myocarditis.
Myocarditis is an inflammation of the myocardium, but
only 10% of those affected show clinical manifestations
of the disease [2]. Nonetheless, myocarditis is still regarded as an important cause of heart failure in children and
adolescents, particularly athletes, indicating that a low degree of inflammation could be present in the hearts of apparently healthy individuals. This hypothesis was supported by a study of autopsies in more than 12,000 accidental
deaths, which showed evidence of lymphocytic myocarditis
in 1.06% of individuals [3], raising a question as to the trigger
of inflammation in heart tissues. Furthermore, as a sequel to

myocarditis, affected individuals can develop dilated cardiomyopathy (DCM) [4]. Approximately half of patients with
DCM undergo heart transplantations due to the lack of effective chemotherapy. Enteroviruses are commonly suspected in DCM patients because the genomic material can be detected in up to 70% of patients, and serologically, virus-reactive neutralizing antibodies can be found in 50% of patients
[2]. The question to be addressed is how virus infection can
promote DCM. Autoimmunity is one possible mechanism,
as evidenced in patients with myocarditis/DCM by the presence of autoantibodies to various cardiac antigens, such as
cardiac myosin heavy chain (Myhc)-α, adenine nucleotide
translocator (ANT), β-adrenergic receptor-1, branched chain
α-ketoacid dehydrogenase (BCKD), laminin, and muscarinic
receptor; Myhc-α is a well-characterized antigen [5,6].
Based on cellular infiltrations, forms of myocarditis have
been classified as lymphocytic, giant cell, and eosinophilic,
and various infectious (viruses, bacteria, protozoa, helminthes) and noninfectious (drugs, metals, chemicals) agents
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have been implicated in the causation of myocarditis. Prominent among the infectious causes are viruses, importantly enteroviruses like coxsackievirus B3 (CVB3). To study the immune events of myocardial injuries in CVB3 infection, various rodent models have been developed. For example, the
virus induces myocarditis in susceptible strains of A/J (H2a) and Balb/C (H-2d) mice, the histologic features of which
resemble those in human disease [7].The disease course has
two distinct stages that occur in continuum: the acute phase,
in which infectious virus is present causing damage to cardiac myocytes; and the chronic phase, in which inflammation
persists, although the extent of virus replication is much reduced due to selection of a defective virus [8,9]. This is consistent with the observation that infectious CVB3 cannot be
isolated in cardiac tissues from patients with DCM [2,10].
The long-standing question is whether this inflammatory
process occurs due to an autoimmune response to cardiac
antigens. Importantly, the same strains of mice that are susceptible to chronic myocarditis and DCM after viral infection also are susceptible to disease induction by immunization with Myhc-α. In contrast, the strains that develop only
limited acute myocarditis are resistant to Myhc-α-induced
disease [11]. In addition, susceptible mice made tolerant to
Myhc-α fail to develop myocarditis after viral infection [12].
It was previously shown that lymphocytes isolated on day
7 postinfection (PI) from Balb/C mice infected with CVB3
were lytic to cardiomyocytes, but their putative target antigens were not characterized [13,14]. Furthermore, these cytotoxic lymphocytes induced the disease in naïve mice infected with or without CVB3 prior to the transfer [14,15]. While
these observations point to a role for autoreactive T cells in
the mediation of CVB3 myocarditis, it is critical to delineate
both the mechanisms of their generation and their target antigens in cardiac tissues.
With the establishment of experimental autoimmune myocarditis (EAM) disease models induced with various cardiac antigens, it is now generally accepted that autoreactive
CD4 T helper (Th) cells play a pivotal role in the mediation
of autoimmune myocarditis [16]. The relevance of autoreactive CD4 T cells is further emphasized by the fact that histologic features of EAM closely mimic those of postinfectious
myocarditis induced with CVB3 [6,8]. Therefore, to study the
role of autoreactive CD4 T cells in the occurrence of CVB3
myocarditis, we recently created major histocompatibility complex (MHC) class II/IAk dextramers for Myhc-α 334–
352, which permitted us to enumerate the frequencies of antigen-specific T cells in infected mice. Using these reagents,
we demonstrated that A/J mice infected with CVB3 develop myocarditis accompanied with the generation of Myhcα-specific CD4 T cells and they infiltrate into the hearts of
infected animals. We noted that the autoreactive T cells obtained from CVB3-infected mice contain a significant proportion of interleukin (IL)-17-producing cells capable of inducing myocarditis in naïve mice.
2. Materials and methods
2.1. Mice
Six-to-eight-week-old A/J and B10.A mice were procured
from the Jackson Laboratory (Bar Harbor, Maine). The mice
were maintained according to the animal protocol guidelines
of the University of Nebraska-Lincoln, Lincoln, Nebraska.

2.2. Virus propagation, titration, and disease-induction
Vero cells (ATCC, Manassas, Virginia) were grown to 80
to 90% confluence in 75 cm2 flasks in EMEM supplemented with 10% fetal bovine serum (FBS). After removing the
medium, the adherent monolayer of cells was infected with
CVB3 (Nancy strain, ATCC) with multiplicity of infection 1
in EMEM containing no FBS [9]. The virus was allowed to
adsorb to the cells by incubating the flasks at 37°C for 1 h
with gentle intermittent rotations every 10 to 15 min. Maintenance medium containing 2% FBS was then added and incubation was continued. After confirming the cytopathic effect (CPE) of the virus, the infected culture flasks were subjected to three rounds of freezing and thawing, and the culture supernatants containing virus were harvested by centrifuging cell lysates at 6000 rpm for 10 min at 4°C, aliquoted,
and stored at -80°C until further use.
Fifty µl of Vero cells prepared to a density of 5 × 105 cells/ml
in EMEM/10% FBS was added in eight replicates for each dilution of the virus, plus four replicates as controls, in 96-well
plates, which was incubated at 37°C for 1 h. Ten-fold serial
dilutions of virus stock (10-1 to 10-8) were made in EMEM and
50 µl of these suspensions were added into the corresponding replicates, whereas control wells received only EMEM.
The plates were scored for CPE up to 7 days, and 50% tissue
culture infective dose (TCID50) values were determined according to the Reed–Muench method [17].
The virus stock with known titers was diluted in 1 ×
phosphate-buffered saline (PBS) to contain 25 to 1 × 105
TCID50/100 µl, and the virions were injected into A/J mice
i.p., whereas control animals received 1 × PBS only. The animals were monitored for clinical illness and/or mortalities,
if any, and the surviving animals were sacrificed on day 21
postinoculation. Hearts and pancreases were harvested for
histology, spleens and lymph nodes (LN) were collected for
in vitro experimentation.
2.3. Histopathology
Hearts and pancreases were fixed by immersion in 10%
phosphate buffered formalin, and three cross-sectional levels of each were sectioned in 5 µm thickness and stained with
hematoxylin and eosin (H and E) [18]. Hearts and pancreases were evaluated for inflammation and necrotic changes
and scored for severity based on the numbers of inflammatory foci added across all sections. The degree of inflammation
was scored as normal (0), mild multifocal (1–5 foci), moderate multifocal to coalescing (6–25 foci), and severe (26 or
more foci) [19].
2.4. Peptide synthesis
Myhc-α-334–352 (DSAFDVLSFTAEEKAGVYK), cardiac
troponin I (TNI157–171: QALLGTRAKESLDLR), interphotoreceptor retinoid-binding protein (IRBP 201–216: ADKDVVVLTSSRTGGV), and bovine ribonuclease (RNase) 43–56
(VNTFVHESLADVQA) were synthesized on 9-fluorenylmethyloxycarbonyl chemistry (Neopeptide, Cambridge, Massachusetts). All peptides were HPLC-purified (N 90%), identity was confirmed by mass spectroscopy, and dissolved in 1
× PBS prior to use.
2.5. T cell proliferation assay
Single-cell suspensions were prepared from a pool of

CVB3 Infection Leads to the Generation of Myhc-α-Reactive CD4 T Cells in A/J Mice

spleens and LN (hereafter termed lymphocytes) harvested from CVB3-infected mice on day 21 PI, and the cell pellets were resuspended in 1 × ammonium chloride potassium
buffer (Lonza, Walkersville, Maryland) to lyse erythrocytes
as described [19]. Likewise, lymphocytes also were prepared
from naïve mice. After washing, cell pellets were resuspended in RPMI medium supplemented with 10% FBS, 1 mM sodium pyruvate, 4mM L-glutamine, 1 × each of non-essential
amino acids and vitamin mixture, and 100 U/ml penicillin–
streptomycin (Lonza; hereafter called growth medium), and
cell viability was verified by trypan blue staining. Cells werestimulated at a density of 5 × 106 cells/ml in triplicates with
the indicated peptides (0–100 µg/ml) for 2 days in growth
medium; the cells cultured with no peptides served as medium controls. Proliferative responses were measured as
counts per minute (cpm) after pulsing with tritiated 3[H] thymidine (1 µCi per well; MP Biomedicals, Santa Ana, California) for 16 h using a Wallac liquid scintillation counter (Perkin Elmer, Waltham, Massachusetts) [20,21]. Stimulation indices were then derived by dividing the cpm values obtained
in peptide-stimulated cultures by those of background values obtained in medium controls [19].
2.6. Determination of antigen specificity of Myhc-α-reactive
T cells by IAk/dextramer staining
IAk dextramers for Myhc-α 334–352 and RNase 43–56 were
derived as described previously [22]. Briefly, soluble IAk
molecules containing the above peptide sequences were
expressed in baculovirus and the proteins were biotinylated [23]. Multimerized dextramers were generated by mixing biotinylated IAk proteins with phycoerythrin-conjugated dextran molecules at a 1:20 molar ratio [22].To determine
the frequency of antigen-specific cells, lymphocytes derived
from CVB3-infected mice were stimulated with Myhc-α 334–
352 (100 µg/ml) for 2 days and maintained in growth medium containing IL-2 (eBioscience, San Diego, California; Advanced Biotechnologies, Columbia, Maryland). Viable lymphoblasts were harvested on day 5 by Ficoll-Hypaque density gradient centrifugation, and the cells were maintained
in IL-2 medium. The staining was performed on day 9 using
IAk/Myhc-α 334–352 or RNase 43–56 dextramers, anti-CD4
(eBioscience), and 7-aminoactinomycin D (7-AAD; Invitrogen, Carlsbad, California) as previously described [22,23].
After acquiring the cells by flow cytometry (FC; FACSCalibur, BD Biosciences, San Diego, California), percentages of
dextramer-positive (dext+) cells were determined in the live
(7-AAD-) CD4+ subset using Flow Jo software (Tree Star,
Ashland, Oregon).
For enumeration of Myhc-α-specific cells ex vivo,CD4 T
cells were enriched by magnetic separation (IMag, BD Biosciences, San Jose, California), and the cells were treated with
neuraminidase (NASE; Type X from Clostridium perfringens,
0.7 units/ml, Sigma-Aldrich, St. Louis, Missouri) in serumfree 1 × DMEM medium prior to dextramer staining, as we
have described previously [21,23]. After washing once with
5 ml of 1 × PBS, cells were stained with IAk dextramers, anti-CD4, and 7-AAD, and dext+ cells were analyzed in the live
(7-AAD-) CD4 subset as above. To determine the frequencies of Myhc-α-reactive cells in the hearts, after the animals
were euthanized, hearts were perfused with an injection of
10 ml of 1 × cold PBS into the left cardiac ventricles, then
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hearts were collected and minced. The tissue suspensions
were incubated with a buffer containing 1 × PBS, collagenase IV (Worthington, Lakewood, New Jersey), and 2% FBS
at 37°C for 15 min in a shaker with continuous agitation. The
digested tissues were passed through an 18 G needle and incubated for an additional 10 min; cell pellets were obtained
by centrifugation and resuspended in 40% buffered percoll. Cell suspensions were then overlaid with 75% percoll
and centrifuged, and the interphase representing mononuclear cells (MNC) was collected and washed [24]. The identities of different subsets of MNC were verified by FC. Finally, MNC were stained with Myhc-a 334–352 or RNase 43–56
dextramers, anti-CD4, and 7-AAD, and frequencies of Myhcα-specific cells were determined as above.
2.7. Intracellular cytokine staining
To enumerate the frequencies of cytokine-producing cells
in naïve mice, lymphocytes were stimulated with phorbol
12-myristate-13 acetate (PMA: 20 ng/ml) and ionomycin (300
ng/ml; Sigma-Aldrich) for 5 h in the presence of 2 mM monensin (Golgi stop, BD Pharmingen, San Diego, California)
[20,25]. After staining with anti-CD4 and 7-AAD, cells were
fixed, permeabilized, and stained with anti-cytokine antibodies or isotype controls (eBioscience), and acquired by FC.
Frequencies of cytokine-producing cells were then enumerated in the live (7-AAD-) CD4+ subset. Likewise, cytokineproducing cells from CVB3-infected mice were analyzed ex
vivo as above. However, to determine the frequencies of cytokine-producing autoreactive T cells from CVB3-infected
mice, lymphocytes were stimulated with Myhc-α 334–352
(100 µg/ml) for 2 days and the cultures were maintained in
IL-2 medium. On day 5, cells were stimulated with PMA and
ionomycin, and frequencies of cytokine+ CD4 T cells were
determined as above. The clones of anti-cytokine antibodies
used were: interferon (IFN)-γ (XMG1.2), IL-4 (11B11), IL-10
(JES5-16E3), IL-17A (eBio17B7), IL-17F (eBio18F10), granulocyte macrophage colony-stimulating factor (GM-CSF, MPI22E9), all from eBioscience; and IL-22 (140301; R&D Systems,
Minneapolis, Minnesota).
2.8. Adoptive transfer myocarditis
Groups of A/J mice were infected with CVB3 (50 TCID50/
animal), and 21 days later, spleens, and LN were collected
and single cell suspensions were prepared [26]. Cells were
stimulated with Concanavalin-A (Con-A; 1 µg/ml) for 2 days
and viable lymphoblasts were harvested and transferred i.p.,
into whole body irradiated naïve A/J mice (400 rads/ animal; 12×107 cells/animal). Each mouse additionally received
pertussis toxin (PT, 100 ng; List Biologicals, Campbell, California) on days 0 and 2 posttransfer as described previously
[19,27,28]. The animals were euthanized on day 21 posttransfer, and hearts and pancreases were collected for histological evaluation of inflammatory changes. To address whether
Myhc-α-reactive CD4 T cells generated in infected mice can
transfer the disease, we first stimulated the lymphocytes obtained from CVB3-infected mice with Myhc-α 334–352 (100
µg/ml) for 2 days and the cultures were maintained in IL-2
medium. On day 5 poststimulation, CD4 T cells were isolated by magnetic separation, and after resting for 2 days in
growth medium, cells were expanded with Con-A for 24 h,
and transferred into naïve mice (0.18×107 cells/animal). The
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animals were euthanized on day 14 and the tissues were evaluated for histology. In addition, the animals that received saline and Con-A-stimulated lymphocytes obtained from naïve
mice were used as controls (0.5×107 cells/animal; n=3). To
provide specificity for CVB3-mediated myocarditis, we used
influenza virus strain, A/Puerto Rico 8/34 (PR8) grown in
the allantoic cavity of embryonated hen’s eggs [29]. Groups
of A/J mice (n = 5) were infected intranasally with 500 egg
infectious units of virus in 30 µl of 1 × PBS under light isoflurane anesthesia and after 10 days, animals were euthanized
to obtain lymphocytes from LN and spleens. Cells were stimulated with Con-A as above for 2 days and viable cells were
transferred into naïve mice (0.3×107 cells/animal). Animals
were euthanized on day 14 posttransfer and hearts and pancreases were harvested for histology. Likewise, to provide
specificity for Myhc, adoptive transfer experiments were
performed using lymphocytes sensitized with IRBP 201–216
as an irrelevant antigen. Briefly, A/J mice were immunized
with IRBP 201–216, an IAk-binder [30] in complete Freund’s
adjuvant (50 µg/mouse: n = 2) and 10 days later, the animals were euthanized to harvest lymphocytes from LN and
spleens. Cells were stimulated with Con-A for 2 days and viable cells were administered into naïve mice (0.75×107 cells/
animal), and on day 14, the animals were euthanized to collect tissues for histology.
2.9. Detection of CVB3 RNA by RT-PCR
Total RNA was isolated from heart and pancreas homogenates, Con-A-stimulated lymphoblasts used for adoptive
transfer experiments, Vero cells cultured with the cell medium used for suspending the lymphoblasts or Vero cells infected with CVB3 using RLT buffer containing guanidium thiocyanate (RNeasy kit, Qiagen, Valencia, California), and the
samples were treated with RNAse-free DNAse I according to
the manufacturer’s recommendations (Qiagen). To make certain that the RNA samples were free of residual DNA, a second round of DNAse digestion was performed using amplification grade DNAse I (Invitrogen), and cDNAs were synthesized utilizing Superscript III reverse transcriptase kit as
recommended (Invitrogen). CVB3 viral protein (VP)1 fragment was then amplified by PCR using VP1-specific primers (forward, 5’TTGCATATGGCCCAGTGGAAG3’; reverse,
5’TGTGGATCCTTATTGCCTAGTAGTGGTAACTC3’). The
PCR products were stained with ethidium bromide and resolved in 1% agarose gel electrophoresis.
2.10. Statistics
Differences in the T cell proliferative responses, frequencies of dext+ cells and cytokine secretion between treatment
groups were analyzed by Student’s t. P ≤ 0.05 values were
considered significant.
3. Results
3.1. Establishment of CVB3-induced myocarditis in A/J mice
We used myocarditis-susceptible A/J mice to induce the
disease with CVB3. Determination of an autoimmune response in this model required establishment of a disease
course in which the virus does not induce significant mortalities. This was achieved using different amounts of virus
inocula and assessing disease severity by evaluating hearts
and pancreases for histological evidence of inflammatory

changes. The dose of 50 TCID50/animal resulted in 20% mortality of the infected animals, whereas doses ranging from
1×103 to 1×105 TCID50 led to high mortalities (89% to 100%)
as early as 5 to 14 days PI (Table 1). Regardless of mortalities,
however, 50% of infected animals had myocardial necrosis,
which occurred in association with pancreatitis, but the degree of inflammatory changes varied. For example, high viral
doses (1×103 to 1×105 TCID50) resulted in mild inflammatory
heart lesions composed of fewer perivascular lymphocytes,
but all animals had severe necrosis; on the other hand, at low
doses the inflammatory foci were widespread (50 TCID50:
11.90 ± 4.50; 100 TCID50: 14.30 ± 5.72), but necrosis was noted
in only 34% of mice (Figure 1 and Table 1). Such an inverse
relationship might be due to limited time available for immune events to set in as a result of early mortalities. However, necrosis and atrophic changes were evident in the pancreases of all infected animals (Figure 1). These features were
lacking in tissues harvested from the control group (data not
shown). Based on our data, we chose a dose range of 50 to
100 TCID50/animal for further experiments to investigate the
induction of autoreactive T cells in infected mice.
3.2. A/J mice infected with CVB3 show generation of Myhcα-reactive cells in their periphery
To address the hypothesis that CVB3 infection induces generation of autoreactive cells, we used Myhc-α as a putative
target cardiac antigen [31]. Two approaches were adopted
to evaluate the generation of Myhc-α-reactive CD4 T cells: 1)
proliferative response to Myhc-α 334–352 based on 3[H] thymidine incorporation assay, and 2) IAk/dextramer staining.
Lymphocytes isolated from A/J mice infected with CVB3
on day 21 PI were tested for responses to Myhc-α 334–352
or RNase 43–56 (control). Figure 2A shows that the cells responded dose dependently to Myhc-α 334–352, and the response was specific since the cells did not respond to the control peptide. Stimulation indices obtained for each peptide
revealed 2.5-fold higher proliferative responses for Myhc-α
334–352 than for RNase 43–56. We next tested antigen specificity of these cells using IAk/dextramers which permitted us
to enumerate the frequencies of Myhc-α -specific CD4 T cells
by FC [22]. CD4 T cells were enriched from infected mice by
magnetic separation and treated with NASE prior to dextramer staining [22]. NASE treatment is critical for ex vivo
determination of antigen-specific cells since it facilitates efficient binding of class II tetramers or dextramers [23]. Under these conditions, we estimated the frequencies of Myhcα-specific cells to be 0.1 ± 0.003%, whereas the staining intensity obtained with RNase 43–56 dextramers was significantly
low (p = 0.002; Figure 2B). We verified these results by stimulating the lymphocytes harvested from CVB3-infected mice
with Myhc-α 334–352, collecting lymphoblasts on day 9 poststimulation, and staining with dextramers. Myhc-α 334–352
dextramers detected 3 times more CD4 cells than were detected with RNase 43–56 dextramers (0.46 ± 0.08% vs. 0.14
± 0.01%; p = 0.015; Figure 2C). Expectedly, the number of
Myhc-α-reactive cells detected in Myhc-α 334–352-stimulated cultures increased by 5-fold over ex vivo analysis. The
specificity of T cell responses to Myhc-α 334–352 was further verified by stimulating the lymphocytes obtained from
CVB3-infected mice with a non-myocarditogenic heart anti-
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gen, TNI 157–171 [32]. Figure 2D shows that the lymphocytes
obtained from CVB3-infected mice did not respond to TNI
157–171 and the response was similar to control, RNase 43–
56. Finally, we asked whether Myhc-α-reactive T cells can
be generated in myocarditis-resistant mice. To address this
question, we used B10.A mice bearing H-2a haplotype similar to A/J mice which are resistant to the development of
myocarditis induced with CVB3 [33,34]. In a T cell proliferation assay, we noted that lymphocytes obtained from infected B10.A mice did not respond to Myhc-α 334–352 (Figure
2E). Overall, the data obtained with dextramer stainings and
proliferative responses corroborate each other and provide
evidence for the generation of Myhc-α-reactive cells in mice
susceptible to CVB3 infection.
3.3. Myhc-α-specific cells infiltrate into the hearts of CVB3infected mice
We sought to verify whether Myhc-α-specific cells infiltrate
the hearts. MNC were harvested from hearts of CVB3-infected mice and stained with Myhc-α 334–352 or RNase 43–56
dextramers, and frequencies of Myhc-α-dext+ cells were determined by FC. We prepared pools of MNC from at least
seven hearts for each experiment because the yield of cells
per heart was low (6×104/heart). The majority of infiltrates
were non-T cells, and staining for different immune cell
markers revealed the presence of B220+ (8.5%), GR1+ (6.5%),
CD11b+ (2.8%), and CD11c+ cells (1.4%). In contrast, CD3+ T
cells formed a minor component consisting of CD4+ (8%) and
CD8+ (4%) T cells (Figure 3A). Dextramer analysis of CD4 T
cells revealed autoreactive cells as evidenced by the presence
of an estimated 2.2±0.16% of Myhc-α 334–352 dext+ cells, as
opposed to 0.6±0.07% of RNase 43–56 cells, an four-fold
difference (p=0.011, Figure 3B). The data provide evidence
that Myhc-α 334–352-reactive CD4 T cells infiltrate the hearts
during the course of CVB3 infection in A/J mice.
3.4. Naïve A/J mice do not carry Myhc-α-reactive CD4 T
cells in their peripheral repertoires
One critical question we needed to address was whether
Myhc-α-reactive cells generated in CVB3-infected mice arise
from expansion of a preexisting repertoire of autoreactive
cells or appear as a new population of cells after viral infection. We obtained lymphocytes from naïve (uninfected) A/J
mice and evaluated their reactivity to Myhc-α 334–352 by T
cell proliferation assay and dextramer staining. Using RNase
43–56 as control, we noted that T cells did not respond to
Myhc-α 334–352 (Figure 4A) nor was there any staining with
Myhc-α dextramers (Figure 4B). Absence of Myhc-α-reactive
cells in the naïve repertoires but their presence in CVB3-in-

fected animals implies that autoreactive T cells appear secondary to virus infection, likely as the result of virus-induced tissue damage.
3.5. Myhc-α-reactive CD4 T cells generated in response to CVB3
infection contain a high frequency of IL-17-producing cells
To determine the pathogenic potential of Myhc-α-reactive
cells generated in mice infected with CVB3, we determined
their cytokine-producing abilities by intracellular staining.
Frequencies of cytokine-producing cells were enumerated
in naïve mice to determine background response of cytokine
production prior to exposure to the virus. The naïve T cell
repertoires contained predominantly IL-2-producing cells
(data not shown), whereas cells capable of producing other cytokines except IFN-γ were lacking (1.25±0.03%; Figure
5). Examination of cytokine-producing abilities of lymphocytes harvested from CVB3-infected mice ex vivo revealed
elevated levels of all cytokines tested – Th1, Th2, and Th17
– but among these, frequencies of cells secreting IL-22 (2.75±
0.34%; p=0.002) and GM-CSF (0.36±0.03%; p=0.006) were
significantly increased, followed by cells producing IFN-γ
(2.69±0.66%), IL-17F (1.56±1.25%), IL-10 (0.89±0.29%), IL-17A
(0.24±0.07%), and IL-4 (0.19±0.08%; Figure 5). Next, we evaluated the frequencies of cytokine-secreting autoreactive T
cells by stimulating lymphocytes harvested from CVB3-infected mice with Myhc-α 334–352, resulting in the expansion
of IFN-γ-, IL-4-, IL-17A-, IL-17F-, and GM-CSF-producing
cells, but the prominent cytokine was IL-17A (0.51±0.04%,
p=0.033; Figure 5). The data suggest that Myhc-α-reactive
cells generated in CVB3-infected mice possess the pathogenic characteristics of autoreactive T cells as indicated by their
preferential ability to produce IL-17.
3.6. T lymphocytes generated from CVB3-infected mice can
induce myocarditis in naïve mice
To determine if the autoreactive cells generated in mice
infected with CVB3 have an ability to induce myocarditis,
we derived lymphoblasts from infected mice by stimulating
lymphocytes with Con-A and injecting them into naïve irradiated recipients as previously described [35,36]. One of
the three recipients of cells derived from CVB3-infected mice
showed epicarditis (Figure 6A: i), myocarditis (Figure 6A:
ii) and myocardial fibrosis (Figure 6A: iii) and the pancreas was not affected and the infiltrates were predominantly
composed of lymphocytes similar to EAM [19]. Likewise, the
animals (2/2) that received Myhc-α 334–352-sensitized CD4
T cells also showed cardiac damage as indicated by hemorrhagic necrosis (Figure 6B: i) and mineralization (Figure 6B:
ii). On the contrary, none of the saline-receiving

Table 1 CVB3-induced myocarditis in A/J mice.
Does (TCID50/animal 		Incidence n (%) 		Mortality n (%) 		
														
2.5×101 					 1/3 (33.33) 			 1/3 (33.33) 			
5.0×101 					12/55 (21.81) 			11/55 (20) 			
1.0×102 					13/33 (39.39) 			22/35 (62.85) 			
1.0×103 					 5/9 (55.55) 			 9/9 (100) 			
1.0×104 					 4/9 (44.44) 			 8/9 (88.88) 			
1.0×105 					 5/8 (62.5) 			 8/8 (100) 			
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Severity of lesions 			
Inflammatory foci (mean±SEM)
Mild
Moderate
Severe
0 		
1 			
0 			 66.66±6.66
3 		
3 			
6 			 11.90±4.49
6 		
2 			
5 			 14.30±5.72
3 		
2 			
0 			
2.55±1.36
4 		
0 			
0 			
1.13±0.52
4 		
1 			
0 			
2.00±0.93

Inflammation scoring scale: mild multifocal: 1-5 foci; moderate multifocal to coalescing: 6-25 foci; and severe: 26 foci and above.
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Figure 1 Histological evaluation of hearts and pancreases from mice infected with CVB3. Groups of 6- to 8-week old A/J mice were infected with
CVB3 (1×102 TCID50/animal) i.p., and animals were killed on day 21 PI. Hearts (A to D) and pancreases (E and F) were collected for histological
evaluation of inflammatory changes by H and E staining. (A) Mild lesion with a few perivascular lymphocytes (arrow) and dark pink fibers indicative of necrosis (circle). (B) Moderate lesions with more foci and necrosis (arrows). (C) Severe inflammatory lesion with widespread areas of
mineralization (arrows). (D) Necrosis, mineralization, or lymphocytic and histiocytic infiltrates (arrows). (E) Pancreatic ducts (arrow) and small
acinii composed of atrophic acinar cells and (F) widespread acinar cell necrosis with nuclear pyknosis (arrows) and loss of cytoplasmic details.
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Figure 2 A/J mice infected with CVB3 show the generation of Myhc-a 334–352 reactive cells. (A) Proliferative response. A/J mice were infected
with CVB3 (5×101 to 1×102 TCID50/animal); after 21 days, animals were sacrificed and spleens and LN were harvested to prepare lymphocytes.
Cells were stimulated with Myhc-α 334–352 for 2 days, then pulsed with 3[H] thymidine for 16 h, and proliferative responses were measured
as cpm. (B) Dextramer staining ex vivo. CD4 T cells isolated from CVB3-infected mice were treated with NASE prior to staining with IAk/dextramers, anti-CD4, and 7-AAD. After acquiring the cells by FC, dext+ cells were analyzed in the live (7-AAD-), CD4 subset. Control, RNase 43–
56. (C) Dextramer staining of Myhc-α 334–352-stimulated cells. Lymphocytes were obtained from CVB3-infected mice as above; cells were stimulated with Myhc-a 334–352 for 2 days and cultures were maintained in IL-2 medium. Viable lymphoblasts were harvested on day 9 poststimulation and stained with IAk/dextramers, anti-CD4 and 7-AAD. After acquiring the cells by FC, dext+ cells were analyzed in the live (7-AAD-),
CD4 subset. Control, RNase 43–56. (D) Proliferative response to TNI 157–171. Lymphocytes harvested from CVB3-infected A/J mice were stimulated with TNI 157–171 and RNase 43–56 for 2 days and the proliferative responses were measured as cpm after pulsing with 3[H] thymidine
for 16 h. (E) Proliferative response to Myhc-α 334–352 in B10.A mice. B10.A mice were infected with CVB3 (1×102 TCID50/mouse) and after 21
days, the animals were euthanized to prepare single cell suspensions from LN and spleens. After stimulating the cells with Myhc-α 334–352 and
RNase 43–56 for 2 days, and pulsing with 3[H] thymidine, proliferative responses were measured as above.
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animals (Figure 6C), or those that received Con-A-stimulated naïve lymphocytes (Figure 6D), influenza virus-sensitized
lymphocytes (Figure 6E) and IRBP 201–216-reactive lymphocytes (Figure 6F) showed any evidence of inflammation in
the hearts or in the pancreases. To verify whether myocarditis occurring in the recipient mice was caused by residual virus present in the infused cells, we tested the lymphocyte
cultures used for infusions for the presence of virus by CPE,
and for the presence of viral nucleic acids by RT-PCR. Vero
cells infected with CVB3 as a positive control showed cytolysis, but such a phenomenon was absent when the culture
medium was passed thrice blindly, including the viral nucleic acids as verified for CVB3 VP1 (819 bp) by RT-PCR (lane,
14; Figure 7). Likewise, the presence of CVB3 RNA was not
revealed in the evaluation of hearts and pancreases of mice

Figure 3 Myhc-α-specific CD4 T cells infiltrate into the hearts of
CVB3-infected mice. (A) Subsets of heart infiltrates. Groups of mice
infected with CVB3 (5×101 TCID50/animal) were sacrificed on day 21
PI, and hearts were collected to isolate MNC. Cells were stained with
the indicated markers and percentages of each were determined by
FC. The data represent an experiment involving 13 mice. (B) IAk/
dextramer staining. Heart MNC isolated from CVB3-infected mice
were stained with Myhc-α 334–352 or RNase 43–56 (control) dextramers and anti-CD4 and 7-AAD. Cells were acquired by FC, and
percentages of dext+ cells were enumerated in the live CD4 subset.
Representative data from two individual experiments, each involving 7 to 8 mice, are shown.

that received saline (lanes, 1–6) or cells (lanes, 7–12; Figure
7). The data suggest that CVB3 infection can lead to the generation of Myhc-α-reactive cells and they can contribute to
the development of myocarditis in infected animals.
4. Discussion
In this report, we show that the T cell repertoire generated
in response to CVB3 infection contains a population of Myhcα-reactive cells. We provide four lines of evidence for a proposal that the autoreactive cells are generated secondary to
CVB3 infection and play a role in the mediation of viral myocarditis: a) the peripheral repertoire of infected but not naïve
mice contains a population of Myhc-α 334–352 dext+ cells;
b) the inflammatory infiltrates of hearts from CVB3-infected
mice reveal the presence of Myhc-α-reactive cells; c) lymphocytes stimulated with Myhc-α 334–352 contain high frequencies of IL-17-producing cells, a cytokine generally implicated in various organ-specific diseases including autoimmune
and CVB3 myocarditis or DCM [37–39]; and d) T cells generated from CVB3-infected mice can induce disease in naïve mice reminiscent of autoimmune myocarditis induced
with Myhc-α 334–352 [16,19]. All these studies employed
A/J mice, which are highly susceptible to both human-isolate CVB3 (Nancy strain) infection, and Myhc-α 334–352-induced EAM, whose disease pathologies resemble each oth-

Figure 4 Naïve mice do not carry Myhc-α 334–352-reactive T cells
in their periphery. (A) Proliferative response. Lymphocytes were
isolated from spleens and LN harvested from naïve mice, and cells
were stimulated with Myhc-α 334–352 or RNase 43–56 for 2 days;
after pulsing with 3[H] thymidine for 16 h, proliferative responses
were measured as cpm. (B) Dextramer staining ex vivo. CD4 T cells
isolated from naïve mice were treated with NASE prior to staining
with IAk/dextramers followed by anti-CD4 and 7-AAD. After acquiring the cells by FC, dext+ cells were analyzed in the live (7-AAD), CD4 subset. Control, RNase 43–56. FC plots representing three individual experiments each involving three mice are shown.
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er [11]. Therefore, the CVB3-induced myocarditis model provides a useful framework to extrapolate the observations
made in mice to humans.
Autoimmune theory has been proposed in the pathogenesis
of CVB3 infection, particularly in the heart, because the disease assumes a biphasic pattern: acute or viremic and chronic or non-viremic phases, although in the latter phase, the virus can persist but in a defective form [8,9]. Generally, autoimmunity becomes a prime suspect in chronic diseases when
inflammation persists in the absence of detectable infectious
particles. The challenge, then, is to provide support for the
concept that autoimmunity is a component of the disease
process to establish a cause-and-effect relationship.
Extensive investigation of the role of cell-mediated immune
response in CVB3 infection has shown that it requires participation of both CD4 and CD8 T cells. Mice deficient in CD4
become resistant to CVB3-induced myocarditis, whereas
CD8-deficient mice develop more or less severe myocarditis
[40,41]. Conversely, mice deficient in both CD4 and CD8 are
better protected from the disease [40]. In addition, γδ T cells
promote susceptibility to CVB3-induced myocarditis by potentiating the expansion of Th1 cells [15]. These observations
indicate that multiple immune cells are involved in the mediation of viral myocarditis. Generally, T cell-mediated organ-specific autoimmune diseases such as experimental autoimmune encephalomyelitis/multiple sclerosis are primarily driven by Th1 and Th17 cells [42]. An exception to this paradigm was earlier proposed to be myocarditis, in that Th1
cells offer disease protection. For example, IFN-γ knockout
mice become susceptible to CVB3-myocarditis, and treatment with IFN-γ ameliorates the disease [43]. Likewise, tissue-specific ectopic expression of IFN-. within the pancreatic beta cells prevents the disease [44]. In contrast to Th1

Figure 5 Myhc-α 334–352-sensitized CD4 T cells from CVB3- infected mice contain a high proportion of IL-17-producing cells. Lymphocytes harvested from naïve mice or from CVB3-infected mice on
day 21 PI were stimulated with PMA and ionomycin in the presence
of monensin for 5 h. After staining with anti-CD4 and 7-AAD, cells
were fixed and permeabilized followed by incubation with a panel
of Th1, Th2 and Th17 cytokine antibodies. Cells were acquired by FC
and frequencies of cytokine-producing cells were determined in the
live (7-AAD-), CD4 subset. To determine the frequencies of cytokineproducing autoreactive T cells, lymphocytes obtained from CVB3infected mice were stimulated with Myhc-a 334–352 for 2 days; cultures were maintained in IL-2 medium. Viable lymphoblasts harvested on day 5 were stimulated with PMA/ionomycin and percentages of cytokine-producing cells were determined as above.
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cells, the role of IL-4- and IL-10-producing Th2 cells is more
complex. Mice infected with CVB3 produce IL-4, which can
dampen the disease-protective Th1 response. IL-4 also can
suppress the production of innate inflammatory mediators,
such as metalloproteinases, and favors recovery from viral
myocarditis [45]. On the contrary, macrophages or human fibroblasts exposed to CVB3 produce both anti-inflammatory
(IL-10) and inflammatory [IL-1β, IL-6 and tumor necrosis factor (TNF)-α] cytokines, and induction of IL-10 is thought to
favor development of the chronic disease course by inhibiting the disease-protective IFN-γ secretion [46,47]. Recently,
it was shown that IL-17 promotes viral myocarditis by enhancing viral replication and that neutralization of IL-17 using cytokine-specific antibody treatment suppresses the severity of disease induced with CVB3 [39]. We observed that
lymphocytes derived from CVB3-infected mice contain a
significant proportion of IL-22 (2.75 ± 0.34%) and GM-CSF
(0.36 ±0.03%). Similar profiles have been earlier reported
[48]. However, after stimulation with Myhc-α 334–352, frequencies of IL-17-producing cells were increased suggesting
a selective expansion of Th17 cytokine-secreting cells by an
autoantigen. We and others have previously demonstrated
that the lymphocytes generated from Myhc-α 334–352-immunized mice contain predominantly IL-17-producing cells
[4,19,37]. Thus our data support the contention that IL-17 is
a myocarditogenic cytokine [49], and IL-17-producing autoreactive T cells could be generated as a secondary event
in infectious myocarditis and contribute to cardiac damage.
CVB3 is a cytolytic cardiotropic virus that causes extensive
damage in the target organ, the heart. The dosages used in
this study were low compared to other models of CVB3-induced myocarditis due to the high rate of mortality in the
A/J mice with this viral strain [14,50]. At dosages of 103 to
105 infectious units, mortality was greater than 80%, whereas
low doses (up to 1×102) induced myocarditis with low mortalities. Cardiovirulent CVB3 causes extensive pancreatic necrosis, which may account for the early mortalities in these
mice [51]. We attempted to determine whether myocarditis that occurred in CVB3-infected mice might be due to the
generation of autoreactive CD4 cells, and our data support
this possibility. We noted that Myhc-α-reactive cells are generated in CVB3-infected but not naïve A/J mice (0.1%, Figure 2B vs 0.04%, Figure 4B) and antigen-specific T cells infiltrate into the hearts of infected animals. The absence of such
a repertoire in naïve mice suggests their appearance secondary to virus infection. Whether naïve A/J mice carry T cell
repertoires for other epitopes of Myhc-α remains to be tested. This possibility seems less likely because Myhc-α 334–
352 was identified as the only immunodominant and pathogenic epitope in this mouse strain [16]. These observations,
however, do not rule out the possibility that virus-specific
cells are not involved. The question is: how do they mediate
cardiac damage in the absence of replicating viral particles?
This can be explained by two scenarios: 1) Virus-specific cytotoxic lymphocytes may expand from a pool of memory T
cell population during subsequent exposures to CVB3, and
the effector cells thus derived can kill virus-infected cardiomyocytes through MHC class I-dependent pathways. Likewise, Th cells capable of secreting inflammatory cytokines
also can potentially expand and contribute to tissue injury or
can do so through the production of autoantibodies. In sup-
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Figure 6 T cells generated from CVB3-infected mice can induce myocarditis in naïve mice. Groups of A/J mice (n=20) were infected with CVB3
and after 21 days, lymphocytes were stimulated with Con-A for 2 days, viable lymphoblasts were administered i.p., into the naïve irradiated
mice (n=3), and each mouse also received PT i.p. The animals were euthanized on day 21 posttransfer, and hearts and pancreases were collected for histological evaluation of inflammatory changes by H and E staining. Panels (A: i), (A: ii), and (A: iii) represent heart sections from mice
that received the cells, respectively denoting epicarditis, myocarditis, myocardial fibrosis accompanied with inflammatory infiltrates (arrows),
and normal pancreas. Likewise, Myhc-α 334–352-sensitized CD4 T cells were also generated from CVB3-infected mice as described in the Materials and methods and transferred into naïve mice. Panels (B: i) and (B: ii) respectively represent hemorrhagic necrosis and mineralization in the
hearts (arrows) but with normal pancreas. Panels (C), (D), (E) and (F) represent histological evaluation of hearts and pancreases obtained from
animals that received saline, Con-A-stimulated naïve lymphocytes, influenza virus-sensitized lymphocytes and IRBP 201–216-reactive cells generated from A/J mice. Bar=20 µm for all except for heart in saline group (C): 50 µm.

port of this theory, mice infected with repeated bouts of virus developed dilated hearts in association with increased
TNF-α secretion and CVB3-reactive antibodies, but with
minimal inflammatory cell infiltrations [52]. 2) Virus-specific
cells may contain repertoires of cells specific to cardiac proteins other than Myhc, and existence of such cross-reactive T
cell repertoires, if any, can induce cardiac injury through antigenic mimicry [53].
In summary, we provide evidence that CVB3-infected mice
show the generation of Myhc-α-reactive cells and they infil-

trate into the hearts of infected animals. Because the naïve
mice lack Myhc-α-reactive cells in their periphery, we propose that generation of autoreactive T cells occurs as a secondary event to cardiac damage. This means previously invisible self-proteins, as in the case of Myhc-α, become targets
for immune attack after viral damage. While our data provide a proof-of-concept for this theory, we cannot rule out
the contribution of autoreactive T cells for other self-antigens
that might be released during the course of CVB3 infection
as a result of epitope spreading [54]. To investigate this pos-
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Figure 7 Detection of CVB3 RNA by RT-PCR. Total RNA was extracted from hearts and pancreases from animals that received saline or lymphocytes and other samples as indicated. After synthesizing cDNAs, PCR amplifications were performed using CVB3 VP1-specific primers. The
ethidium bromide-stained PCR products were resolved in 1% agarose gel electrophoresis.

sibility, we are generating class II dextramers for other cardiac antigens such as BCKD, ANT, and TNI, which will permit us to enumerate the precursor frequencies of their T cell
repertoires in CVB3-infected mice. These observations provide new insights into the immunopathogenesis of CVB3 infection, including therapeutic modalities.
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